In the current study, we demonstrated that miR-206 overexpression inhibited HGF-induced lung cancer EMT, metastasis and angiogenesis by targeting c-Met and its downstream PI3k/Akt/mTOR (mammalian target of rapamycin) pathway. This evidence concerns the gene MET and lung carcinoma.